For distributors
Your market, our engine.
The only wrist device we know of that reads blood sugar and blood pressure together — sold through your channel.
A watch and app that read glucose patterns and blood pressure from one optical sensor. No needle, no patch, no cuff, nothing to refill.
The product
One wrist replaces the stack.
Today your customers piece glucose and blood pressure together from two or three devices — a CGM patch replaced every two weeks, a ring, a cuff. LifeLeaf does it from one watch, with nothing to re-buy.
What it reads
Two signals nobody else puts on one wrist.
Blood sugar (patterns and trends) · blood pressure · heart rate, rhythm and HRV · respiration rate · oxygen saturation.
How it reads
Light, not needles.
One multi-wavelength optical (PPG) sensor, processed on the watch. No calibration required, no fingersticks. Each reading combines the signal with a profile the customer sets once: age, sex, height, weight and skin type.
What the customer gets
An app they open every morning.
The LifeLeaf app on iPhone and Android, with a membership. Three daily scores, glucose patterns with time in range, a 24-hour blood-pressure profile and a shareable report — in the mode that fits them: Longevity, Weight management, On GLP‑1 therapy or Pregnancy.
How one sensor reads both
Glucose: near-infrared absorption at several short-wave wavelengths.
Blood pressure: reflected-wave transit time — the timing shift between wavelength channels tracks arterial stiffness and pressure, with no cuff.
Every signal is filtered for motion, ambient light, sweat and temperature, then quality-checked. When the signal is thin, the app shows a plain note instead of a number. Ten years of work, 11 granted patents, 5 pending and 4 in progress. See the science →
Why now
A category of one, in a market already moving.
As of September 2026, LifeLeaf is the only wrist device we know of that reads blood sugar and blood pressure together. The partners who launch in that window set the category in their market.
Wellness wearables market
$84.8B
growing ~17.5% a year
Grand View Research, 2026
Lead on combined glucose + blood pressure
18–24 months
expected lead
Company estimate
Three buyers, one device.
How we expect the buyer base to widen — same device, same customers.
1 · Now — Wellness
Direct to consumer, Kickstarter, distribution partners. No regulatory gate.
FDA clearance
2 · Disease management
Disease-management platforms, GLP‑1 telehealth, employers.
3 · Next — Therapeutic
Provider prescription and reimbursement.
Company view of how the market develops. LifeLeaf sells today as a general wellness device; we are pursuing regulatory clearances in parallel.
Proof
Already shipping. Already tested where your customers live.
Paying B2B customers outside the US, signed territories, and contracted and committed volume behind them — plus clinical studies run across three continents.
Customers
Shipping
to paying B2B customers
Outside the US, since early 2025.
Territories
Signed
across multiple regions
With more in discussion now.
Contracted
2,200
units contracted
Contracted volume to date.
Committed
11,000+
units committed
Through distribution partners.
Territory conversations are under way in several markets. The earlier we talk, the more options your market has.
Four studies, one headline each.
Glucose vs reference CGM
8.5% MARD
N = 66 · 10,905 paired readings · Bailey et al., ATTD 2023
Glucose vs fingerstick
10.8% MARD
N = 248 across 12 countries, designed to test skin tones · Bailey et al., ADA 2025
BP vs validated cuff
−0.02 mmHg
Systolic bias (SD 12.5) · N = 293 · Almahmeed et al., ESH 2023
BP vs arterial line · Mayo Clinic
R = 0.96
Systolic correlation (0.95 diastolic; lower above 140/90 mmHg) · N = 87 · Sosin et al., AHA 2025
The results presented at ADA this year show that LifeLeaf has the potential to provide accurate data, without invasiveness or complexity. This kind of non-invasive monitoring is uniquely poised to improve patient adherence and enable earlier detection — two critical factors in managing chronic conditions.
Clinical sites · 70,000+ paired readings
Who buys
Four customers you already know how to reach.
Each gets its own mode in the app, with its own scores and coaching. Coaching is behavioural — a walk after meals, slower breathing, an earlier dinner — never medication advice.
On GLP‑1 therapy Beachhead
People on GLP‑1 medication who want to see how their patterns change — and keep up hydration and fueling while they eat less.
Pursuing longevity
Ring and strap wearers who already track sleep and HRV, and want glucose and blood pressure in the same view.
Managing weight
People who want to see how meals, timing and activity move their glucose — without wearing a patch.
Navigating pregnancy
A dedicated mode for glucose and blood-pressure patterns during a period when both matter.
Start in the channel you already run. The clinical channels open as clearance lands — same device, same customers.
Partner economics
Most hardware pays once. This keeps paying.
You get paid twice. Once on the hardware, at a wholesale margin set by volume and market. And then every month the customer keeps their subscription — an ongoing share of recurring revenue, for the life of that customer, at no further cost to you. Most hardware partnerships pay once. This one keeps paying. Partner economics vary per market and per volume. Book a call and we’ll walk you through the model.
What you get
We bring the product, the evidence and the launch kit. You bring the market.
Market alignment
Positioning, the segments to lead with, and the regulatory route for your territory — worked through together before launch.
Launch toolkit
The assets and plan for your first campaign, built around your market.
Training
Product and science training, so your team can explain one sensor, two signals and no consumables in their own words.
Sales and product decks
A distributor deck and a product deck, ready for your buyers and retail partners.
Clinical evidence pack
Study headlines, citations and investigators, ready for pharmacy and clinical conversations.
Co-marketing assets
Product renders, on-wrist photography and app screens for your campaigns and retail.
Path to launch
Four steps from first call to full territory.
Align
Market, positioning, regulatory route.
Equip
The launch toolkit, training, assets.
Pilot
A bounded first market.
Scale
Territory by territory.
Questions partners ask
Before the call.
Is territory exclusivity available?
Are there minimum volumes?
Who handles regulatory registration in my country?
What about customer support and warranty?
How is the membership billed, and how do I earn on it?
Book a call
Tell us about your market.
A few details let us come to the first call prepared for your territory, channel and timing.
Partner overview
Read before you talk.
A one-page overview for distribution partners: the product, the evidence, who buys, and how launch works. Tick the box on the form and we’ll send it to your work email; the full partner deck comes with the call.